Wednesday 29 January 2020 ,
Wednesday 29 January 2020 ,
Latest News
  • China confirms 5,974 virus cases as death toll rises to 132
  • Candidates out to woo voters as electioneering ends today
  • Citizens miffed by loudspeaker use
  • Biker killed in road crash in capital
  • DNCC to procure 42,450 streetlights
5 August, 2019 00:00 00 AM

BIT organizes master-class for Complex PCI of Higher-risk and Indicated Patients

Stethoscope desk
BIT organizes master-class for Complex PCI of Higher-risk and Indicated Patients

Across the world, Illustrious surgeons, physicians and medical scientists often conduct, workshops and master-classes on complex subjects, developments, treatment methods in this ever advancing medical environment. Thus, Bangla Interventional Therapeutics (BIT) takes lead in organizing a master-class in Dhaka last week (29th and 30th July) on Complex PCI of Higher-risk and Indicated Patients (CHIP).

Renowned interventional cardiologist Prof. (Dr.) Afzalur Rahman who is the Chairman and Course Director of this Master-Class comments “I am very pleased that we are holding this prestigious event which many senior interventional cardiologists are attending to enhance learning experiences, improving clinical skills through case-based discussions and live procedures.”

This program is geared toward the Interventional Cardiologists seeking to better understand complex PCI of higher-risk indicated patients in the modern era. Presentations will focus on management of challenging patient subsets, as well as, on how to provide optimal revascularization to those patients.

The program will enhance the learning experience for Interventional Cardiologists as well. Expert faculty will offer insights into selecting devices and patients, optimizing technique, and overcoming difficult anatomy. The latest clinical data and guidelines for complex, higher-risk procedures also will be reviewed.

Another special focus of this master-class would be on zero-contrast angioplasty, which is specially important for the renal disease patients. In fact, the endeavor is for the first time in Bangladesh.

Prof. (Dr.) Afzalur Rahman is the current Director & Professor of National Institute of Cardiovascular Diseases (NICVD), President of the Bangladesh Society of Cardiovascular Intervention (BSCI) and International Governor of ACC (American College of Cardiology). Holding MD and PhD in Cardiology, Dr. Rahman’s contributions in the field of Interventional Cardiology have been recognized extensively in Bangladesh, as well as, across the world. He has more than 135 publications to his credit in prestigious national and International medical journals.

He has trained a good number of cardiologists from Bangladesh and abroad in advanced techniques of angioplasty. Winner of several national and international awards, Dr Rahman indeed is the pride of Bangladesh.

Bangla Interventional Therapeutics (BIT) is a platform for interventional and clinical cardiologists. It is a joint collaboration of interventional and clinical cardiologists around the Globe and has created considerable enthusiasm among the cardiologists across the geographical boundary.

BIT offers a platform to the cardiologists where they can meet together, exchange views and share experience for up-gradation of knowledge and skills, and do the best for the benefit of the people.

Another highlight of this program is participation of Dr. Sanjog Kalra, an eminent expert guest faculty who is Director of Complex Coronary Therapeutics and Associate Director of the Interventional Cardiology Fellowship program at Einstein Medical Center in Philadelphia, Pennsylvania, U.S.A.

 

Comments

Most Viewed
Digital Edition
More story
Editor Speaks

Editor Speaks

Leprosy or Hensen’s Disease is an infectious, chronic granulomatus disease caused by an acid and alcohol fast bacillus called Micobacterium Leprae.…
Q&A on Leprosy

Q&A on Leprosy

What is leprosy? Leprosy is a chronic, progressive bacterial infection caused by the bacterium Mycobacterium leprae. It primarily affects the nerves of…
Leprosy elimination

Leprosy elimination

Leprosy is a chronic infectious disease caused by Mycobacterium leprae, an acid-fast, rod-shaped bacillus. The disease mainly affects the skin, the peripheral…
Global Leprosy Strategy 2016-2020

Global Leprosy Strategy 2016-2020

The past three decades have witnessed some impressive advances in leprosy control. Elimination as a public health problem (i.e. registered prevalence…
Sepsis: Everything you need to know

Sepsis: Everything you need to know

Sepsis is a life-threatening illness caused by body's response to an infection. This infection injures its own tissues and organs, potentially leading…
Mystery virus in Wuhan identified as novel coronavirus

Mystery virus in Wuhan identified as novel coronavirus

Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause…
Belly fat linked with repeat heart attacks

Belly fat linked with repeat heart attacks

Heart attack survivors who carry excess fat around their waist are at increased risk of another heart attack, according to research published today in…
5 Things to do after your child is diagnosed with autism

5 Things to do after your child is diagnosed with autism

KACIE After my daughter was diagnosed with autism, I learned five important lessons I want to pass on to other families. There is a lot more to this list…
BAUS Conf 2020

BAUS Conf 2020

14th  BAUS Conference 2020 of Bangladesh Association of Bangladesh Association of Urological Surgeons was held at Intercontinental Hotel, Dhaka on…
'Alarming' one in five deaths due to sepsis

'Alarming' one in five deaths due to sepsis

JAMES GALLAGHER   One in five deaths around the world is caused by sepsis, also known as blood poisoning, shows the most comprehensive analysis of…
FDA warns of surgical gowns that may not be sterile

FDA warns of surgical gowns that may not be sterile

Certain surgical gowns and surgical packs made by Cardinal Health may not be sterile and should not be used, the U.S. Food and Drug Administration said…
FDA approves Ozempic (semaglutide) for cardiovascular risk reduction in adults with Type 2 Diabetes and known heart disease

FDA approves Ozempic (semaglutide) for cardiovascular risk reduction in adults with Type 2 Diabetes and known heart disease

Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Ozempic (semaglutide) injection 0.5 mg…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting